Loading...

Tecan Group AG

0QLN.L•LSE
Healthcare
Medical - Pharmaceuticals
£175.40
£4.50(2.63%)

Tecan Group AG (0QLN.L) Stock Overview

Explore Tecan Group AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.5/100

Key Financials

Market Cap2.2B
P/E Ratio32.84
EPS (TTM)$9.88
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$152.97
1 Month$144.24
3 Months$161.99
1 Year Target$243.76

0QLN.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Tecan Group AG (0QLN.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $243.76.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.84 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;